The TNM 8th edition: Validation of the proposal for organ - confined (pT2) prostate cancer

Detalhes bibliográficos
Autor(a) principal: Billis,Athanase
Data de Publicação: 2019
Outros Autores: Freitas,Leandro L. L., Costa,Larissa B. E., Barreto,Icleia S., Magna,Luis A., Matheus,Wagner E., Ferreira,Ubirajara
Tipo de documento: Artigo
Idioma: eng
Título da fonte: International Braz J Urol (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000200229
Resumo: ABSTRACT Purpose: The 8th edition of the TNM has been updated and improved in order to ensure a high degree of clinical relevance. A major change in prostate includes pathologically organ - confined disease to be considered pT2 and no longer subclassified by extent of involvement or laterality. The aim of this study was to validate this major change. Materials and Methods: Prostates were step - sectioned from 196 patients submitted to radical prostatectomy with organ confined disease (pT2) and negative surgical margins. Tumor extent was evaluated by a semiquantitative point count method. The dominant nodule extent was recorded as the maximal number of positive points of the largest single focus of cancer from the quadrants. Laterality was considered as either total tumor extent (Group 1) or index tumor extent (Group 2). Time to biochemical recurrence was analyzed with the Kaplan - Meier product limit analysis and prediction of shorter time to biochemical recurrence with Cox proportional hazards model. Results: In Group 1, 43 / 196 (21.9%) tumors were unilateral and 153 / 196 (78.1%) bilateral and in Group 2, 156 / 196 (79.6%) tumors were unilateral and 40 / 196 (20.4%) bilateral. In both groups, comparing unilateral vs bilateral tumors, there was no significant clinicopathological difference, and no significant association with time as well as prediction of shorter time to biochemical recurrence following surgery. Conclusions: Pathologic sub - staging of organ confined disease does not convey prognostic information either considering laterality as total tumor extent or index tumor extent. Furthermore, no correlation exists between digital rectal examination and pathologic stage.
id SBU-1_86dc628e47a6a28cbcddc73030fcdf36
oai_identifier_str oai:scielo:S1677-55382019000200229
network_acronym_str SBU-1
network_name_str International Braz J Urol (Online)
repository_id_str
spelling The TNM 8th edition: Validation of the proposal for organ - confined (pT2) prostate cancerProstateProstatic NeoplasmsPathology, SurgicalABSTRACT Purpose: The 8th edition of the TNM has been updated and improved in order to ensure a high degree of clinical relevance. A major change in prostate includes pathologically organ - confined disease to be considered pT2 and no longer subclassified by extent of involvement or laterality. The aim of this study was to validate this major change. Materials and Methods: Prostates were step - sectioned from 196 patients submitted to radical prostatectomy with organ confined disease (pT2) and negative surgical margins. Tumor extent was evaluated by a semiquantitative point count method. The dominant nodule extent was recorded as the maximal number of positive points of the largest single focus of cancer from the quadrants. Laterality was considered as either total tumor extent (Group 1) or index tumor extent (Group 2). Time to biochemical recurrence was analyzed with the Kaplan - Meier product limit analysis and prediction of shorter time to biochemical recurrence with Cox proportional hazards model. Results: In Group 1, 43 / 196 (21.9%) tumors were unilateral and 153 / 196 (78.1%) bilateral and in Group 2, 156 / 196 (79.6%) tumors were unilateral and 40 / 196 (20.4%) bilateral. In both groups, comparing unilateral vs bilateral tumors, there was no significant clinicopathological difference, and no significant association with time as well as prediction of shorter time to biochemical recurrence following surgery. Conclusions: Pathologic sub - staging of organ confined disease does not convey prognostic information either considering laterality as total tumor extent or index tumor extent. Furthermore, no correlation exists between digital rectal examination and pathologic stage.Sociedade Brasileira de Urologia2019-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000200229International braz j urol v.45 n.2 2019reponame:International Braz J Urol (Online)instname:Sociedade Brasileira de Urologia (SBU)instacron:SBU10.1590/s1677-5538.ibju.2018.0338info:eu-repo/semantics/openAccessBillis,AthanaseFreitas,Leandro L. L.Costa,Larissa B. E.Barreto,Icleia S.Magna,Luis A.Matheus,Wagner E.Ferreira,Ubirajaraeng2019-05-22T00:00:00Zoai:scielo:S1677-55382019000200229Revistahttp://www.brazjurol.com.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||brazjurol@brazjurol.com.br1677-61191677-5538opendoar:2019-05-22T00:00International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU)false
dc.title.none.fl_str_mv The TNM 8th edition: Validation of the proposal for organ - confined (pT2) prostate cancer
title The TNM 8th edition: Validation of the proposal for organ - confined (pT2) prostate cancer
spellingShingle The TNM 8th edition: Validation of the proposal for organ - confined (pT2) prostate cancer
Billis,Athanase
Prostate
Prostatic Neoplasms
Pathology, Surgical
title_short The TNM 8th edition: Validation of the proposal for organ - confined (pT2) prostate cancer
title_full The TNM 8th edition: Validation of the proposal for organ - confined (pT2) prostate cancer
title_fullStr The TNM 8th edition: Validation of the proposal for organ - confined (pT2) prostate cancer
title_full_unstemmed The TNM 8th edition: Validation of the proposal for organ - confined (pT2) prostate cancer
title_sort The TNM 8th edition: Validation of the proposal for organ - confined (pT2) prostate cancer
author Billis,Athanase
author_facet Billis,Athanase
Freitas,Leandro L. L.
Costa,Larissa B. E.
Barreto,Icleia S.
Magna,Luis A.
Matheus,Wagner E.
Ferreira,Ubirajara
author_role author
author2 Freitas,Leandro L. L.
Costa,Larissa B. E.
Barreto,Icleia S.
Magna,Luis A.
Matheus,Wagner E.
Ferreira,Ubirajara
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Billis,Athanase
Freitas,Leandro L. L.
Costa,Larissa B. E.
Barreto,Icleia S.
Magna,Luis A.
Matheus,Wagner E.
Ferreira,Ubirajara
dc.subject.por.fl_str_mv Prostate
Prostatic Neoplasms
Pathology, Surgical
topic Prostate
Prostatic Neoplasms
Pathology, Surgical
description ABSTRACT Purpose: The 8th edition of the TNM has been updated and improved in order to ensure a high degree of clinical relevance. A major change in prostate includes pathologically organ - confined disease to be considered pT2 and no longer subclassified by extent of involvement or laterality. The aim of this study was to validate this major change. Materials and Methods: Prostates were step - sectioned from 196 patients submitted to radical prostatectomy with organ confined disease (pT2) and negative surgical margins. Tumor extent was evaluated by a semiquantitative point count method. The dominant nodule extent was recorded as the maximal number of positive points of the largest single focus of cancer from the quadrants. Laterality was considered as either total tumor extent (Group 1) or index tumor extent (Group 2). Time to biochemical recurrence was analyzed with the Kaplan - Meier product limit analysis and prediction of shorter time to biochemical recurrence with Cox proportional hazards model. Results: In Group 1, 43 / 196 (21.9%) tumors were unilateral and 153 / 196 (78.1%) bilateral and in Group 2, 156 / 196 (79.6%) tumors were unilateral and 40 / 196 (20.4%) bilateral. In both groups, comparing unilateral vs bilateral tumors, there was no significant clinicopathological difference, and no significant association with time as well as prediction of shorter time to biochemical recurrence following surgery. Conclusions: Pathologic sub - staging of organ confined disease does not convey prognostic information either considering laterality as total tumor extent or index tumor extent. Furthermore, no correlation exists between digital rectal examination and pathologic stage.
publishDate 2019
dc.date.none.fl_str_mv 2019-04-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000200229
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000200229
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/s1677-5538.ibju.2018.0338
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Urologia
publisher.none.fl_str_mv Sociedade Brasileira de Urologia
dc.source.none.fl_str_mv International braz j urol v.45 n.2 2019
reponame:International Braz J Urol (Online)
instname:Sociedade Brasileira de Urologia (SBU)
instacron:SBU
instname_str Sociedade Brasileira de Urologia (SBU)
instacron_str SBU
institution SBU
reponame_str International Braz J Urol (Online)
collection International Braz J Urol (Online)
repository.name.fl_str_mv International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU)
repository.mail.fl_str_mv ||brazjurol@brazjurol.com.br
_version_ 1750318076762521600